| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -2.9e+02 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |